STXS · Stereotaxis, Inc.
$1.33
+0.05 (+3.91%)
At close · Jul 29
Market Cap
$125.10M
Shares
97.74M
Stereotaxis, Inc. Earnings Call Transcripts
Every quarterly earnings call for Stereotaxis, Inc. (STXS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼15.9%
$7.66M
−$4.92M
'22 Q3
22-11-10
▼11.4%
$7.30M
−$4.16M
'22 Q4
23-03-03
▼6.9%
$6.55M
−$5.35M
'23 Q1
23-05-09
▲27.7%
$7.86M
−$4.96M
'23 Q2
23-08-10
▲1.9%
$7.80M
−$5.37M
'23 Q3
23-11-09
▼37.5%
$4.57M
−$5.04M
'23 Q4
24-03-04
▲5.1%
$6.88M
−$4.51M
'24 Q1
24-05-13
▼42.7%
$4.50M
−$5.83M
'24 Q2
24-08-12
▲17.9%
$9.20M
−$6.19M
'24 Q3
24-11-12
▲38.9%
$6.34M
−$7.51M
'24 Q4
25-03-03
▲8.6%
$7.47M
−$5.82M
'25 Q1
25-05-12
▲95.4%
$8.80M
−$3.83M
'25 Q2
25-07-17
▼18.8%
$7.46M
−$6.46M
'25 Q3
25-11-12
▲36.3%
$8.64M
−$5.53M
'25 Q4
26-03-09
LATEST
▼15.8%
$6.29M
−$5.86M
'26 Q1
26-05-12
Earnings call
FY26 · Q2
2026-08-11
Q2 2026 Stereotaxis Inc. Earnings Conference Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Stereotaxis, Inc. Q1 FY2026 Earnings Call
Confident tone
MAGIC catheter commercial launch
Disposable revenue transformation
Regulatory approvals (FDA and international)
Revenue
$6.29M
▼ 15.8% YoY Diluted EPS
$-0.06
Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-09
Stereotaxis, Inc. Q4 FY2025 Earnings Call
Confident tone
Regulatory milestones for next-gen products
Digital / platform expansion and new indications
China opportunity with MicroPort
Revenue
$8.64M*
▲ 36.3% YoY Gross margin
50.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Stereotaxis, Inc. Q3 FY2025 Earnings Call
Confident tone
Robotic System Sales and Backlog
MAGiC U.S. Regulatory Path
GenesisX System Launch and FDA Approval
Revenue
$7.46M
▼ 18.8% YoY Diluted EPS
$-0.07
Gross margin
54.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-17
Stereotaxis, Inc. Q2 FY2025 Earnings Call
Confident tone
MAGiC ablation catheter
Financial performance and growth outlook
GenesisX robot launch
Revenue
$8.80M
▲ 95.4% YoY Diluted EPS
$-0.05
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Stereotaxis, Inc. Q1 FY2025 Earnings Call
Confident tone
Regulatory approvals for new product ecosystem
Johnson & Johnson legacy transition headwinds
Genesis X capital system launch
Revenue
$7.47M
▲ 8.6% YoY Diluted EPS
$-0.07
Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-03
Stereotaxis, Inc. Q4 FY2024 Earnings Call
Confident tone
MAGIC Ablation Catheter Commercialization
MAGIC Sweep Mapping Catheter
Regulatory Pathway and FDA
Revenue
$6.34M*
▲ 38.9% YoY Gross margin
50.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Stereotaxis, Inc. Q3 FY2024 Earnings Call
Confident tone
Genesis and Genesis X robotic systems
APT acquisition and catheter recurring revenue
Mapping and guide catheter development
Revenue
$9.20M
▲ 17.9% YoY Diluted EPS
$-0.08
Gross margin
44.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Stereotaxis, Inc. Q2 FY2024 Earnings Call
Positive tone
Capital revenue weakness and backlog
GenesisX next-generation platform
China market and regulatory
Revenue
$4.50M
▼ 42.7% YoY Diluted EPS
$-0.07
Gross margin
73.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Stereotaxis, Inc. Q1 FY2024 Earnings Call
Confident tone
APT Acquisition and Integration
Revenue and Backlog Growth
MAGiC Ablation Catheter Regulatory Progress
Revenue
$6.88M
▲ 5.1% YoY Diluted EPS
$-0.06
Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-04
Stereotaxis, Inc. Q4 FY2023 Earnings Call
Confident tone
Revenue Performance and Volatility
MAGiC Catheter (Proprietary Ablation Catheter)
Robotic System (Genesis / Mobile / Next-Gen)
Revenue
$4.57M*
▼ 37.5% YoY Gross margin
60.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Stereotaxis, Inc. Q3 FY2023 Earnings Call
Revenue
$7.80M
▲ 1.9% YoY Diluted EPS
$-0.07
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Stereotaxis, Inc. Q2 FY2023 Earnings Call
Revenue
$7.86M
▲ 27.7% YoY Diluted EPS
$-0.07
Gross margin
53.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Stereotaxis, Inc. Q1 FY2023 Earnings Call
Revenue
$6.55M
▼ 6.9% YoY Diluted EPS
$-0.07
Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-03
Stereotaxis, Inc. Q4 FY2022 Earnings Call
Revenue
$7.30M*
▼ 11.4% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Stereotaxis, Inc. Q3 FY2022 Earnings Call
Revenue
$7.66M
▼ 15.9% YoY Diluted EPS
$-0.07
Gross margin
59.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Stereotaxis, Inc. Q2 FY2022 Earnings Call
Revenue
$6.15M
▼ 32% YoY Diluted EPS
$-0.07
Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Stereotaxis, Inc. Q1 FY2022 Earnings Call
Revenue
$7.04M
▼ 18.4% YoY Diluted EPS
$-0.06
Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Stereotaxis, Inc. Q4 FY2021 Earnings Call
Revenue
$8.24M*
▲ 20.8% YoY Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Stereotaxis, Inc. Q3 FY2021 Earnings Call
Revenue
$9.11M
▲ 4.6% YoY Diluted EPS
$-0.07
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Stereotaxis, Inc. Q2 FY2021 Earnings Call
Revenue
$9.05M
▲ 69.3% YoY Diluted EPS
$-0.02
Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Stereotaxis, Inc. Q1 FY2021 Earnings Call
Revenue
$8.62M
▲ 49.8% YoY Diluted EPS
$-0.02
Gross margin
69.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Stereotaxis, Inc. Q4 FY2020 Earnings Call
Revenue
$6.82M*
▼ 1% YoY Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Stereotaxis, Inc. Q3 FY2020 Earnings Call
Revenue
$8.70M
▲ 6.1% YoY Diluted EPS
$-0.03
Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Stereotaxis, Inc. Q2 FY2020 Earnings Call
Revenue
$5.35M
▼ 21.4% YoY Diluted EPS
$-0.03
Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Stereotaxis, Inc. Q1 FY2020 Earnings Call
Revenue
$5.76M
▼ 17.9% YoY Diluted EPS
$-0.03
Gross margin
83.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Stereotaxis, Inc. Q4 FY2019 Earnings Call
Revenue
$6.89M*
▼ 5.2% YoY Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1289340
CUSIP
85916J409
13F (30d)
25 filings
25 filers
Visit website
Investor relations